This Sources Sought opportunity from Department Of Defense was posted on May 15, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
SIR Y90 Microspheres
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The U.S. Government, through the Health Readiness Contracting Office at Womack Army Medical Center in Fort Bragg, North Carolina, has issued a Sources Sought Notice to gather market information for the sole-source acquisition of SIR-Spheres® Y-90 resin microspheres and associated materials from Sirtex Medical Inc. This notice is purely for planning purposes and does not constitute a solicitation, contract, or obligation to award; no payment will be made for responses, and failure to respond will not preclude future participation in any subsequent procurement. The intended contract will be awarded via DD Form 1449 under the NAICS code 334517 for Irradiation Apparatus Manufacturing and Product Service Code Q527 for Medical - Nuclear Medicine, with the sole justification being the exclusive availability of SIR-Spheres® Y-90 resin microspheres from Sirtex Medical Inc. for the treatment of unresectable metastatic liver tumors from primary colorectal cancer using adjuvant intra-hepatic artery chemotherapy with FUDR. Respondents are required to provide their company name, point of contact details, phone number, email address, small business socio-economic classification, DUNS number, and CAGE code via email to Frank Fogg by the deadline of May 27, 2026, with no telephonic inquiries accepted. The place of performance is Fort Bragg, North Carolina, and the contracting office is located in Fort Belvoir, Virginia. The Contracting Officer for the action is Amush Collins. No contract clauses, evaluation factors, packaging specifications, delivery terms, inspection criteria, or contract value estimates are included, as this is an early-stage information-gathering effort preceding any formal acquisition.
General Info
Agency
NAICS
Place of Performance
Fort Bragg, NC, 28310, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
This is a Request for Information (RFI) – Sources Sought Notice Only. This notice is issued solely for information and planning purposes only.
The US Government will not pay for any information or administrative costs incurred in response to this notice. Submittals will not be returned to the responder; not responding to this notice does not preclude participation in any further RFQ; IFB or RFP if issued.
Health Readiness Contracting Office -(HRCO), Womack Army Medical Center (WAMC), Fort Bragg, NC 28310, intends to solicit, negotiate, and award a sole sourced contract to Sirtex Medical Inc. 300 Unicorn Park Drive Woburn, MA 01801, United States.
Sirtex Medical Inc will provide SIR-Spheres® Y-90 resin microspheres and other materials used in conjunction with the microspheres. SIR-Spheres® Y-90 resin microspheres are indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine). Additionally, there are no other companies or firms that sells or distribute such items.
The solicitation number is W91YTZ27QA0011, and the resulting award will be made on DD Form 1449 (Order for Commercial Items). This requirement is for commercial supply for the Department of Nuclear Medicine. The NAICS for this requirement is 334517- Irradiation Apparatus Manufacturing, and Product Service Code (PSC)- Q527 Medical- Nuclear Medicine. The point of contact for this requirement is Frank Fogg frank.a.fogg.civ@health.mil. The Contracting Officer is Amush Collins at anush.m.collins.civ@army.mil.
Your email response shall provide the following:
Can you provide supply the following supply:
Sirtex Medical Inc will provide SIR-Spheres® Y-90 resin microspheres and other materials used in conjunction with the microspheres. SIR-Spheres® Y-90 resin microspheres are indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine). Additionally, there are no other companies or firms that sells or distribute such items.
If your company can offer this supply item please respond via e-mail to the POC with:
Name of Company
Point of contact
Phone number
Email address
Identify Your Small Business Socio-Economic Group
DUNS number and CAGE Code
No telephonic inquiries will be responded to
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS